Literature DB >> 31163420

MicroRNA-26a: An Emerging Regulator of Renal Biology and Disease.

Xiaoyan Li1,2, Xiao Pan1,2, Xianghui Fu3, Yi Yang1, Jianghua Chen1, Weiqiang Lin4,5.   

Abstract

MicroRNAs (miRNAs) are short, single-stranded, noncoding RNAs that modulate many key biological processes by simultaneously suppressing multiple target genes. Among them, miR-26a, a conserved miRNA among vertebrates, is highly expressed in various tissues. Accumulating evidence demonstrates that miR-26a plays pivotal roles in cellular differentiation, cell growth, apoptosis, and metastasis, thereby participating in the initiation and development of various human diseases, such as metabolic disease and cancer. More recently, miR-26a was found as a versatile regulator of renal biology and disease. miR-26a is intensively involved in the maintenance of podocyte homeostasis and the actin cytoskeleton. It is also able to modulate the homeostasis and function of mesangial cells. In addition, miR-26a affects the expansion of regulatory T cells in the context of ischemia-reperfusion injury and autoimmune diabetes and thus protects the renal system from immune attack. These available data strongly suggest that renal miR-26a possesses critical pathological functions and represents a potential target for renal disease therapies. This review summarizes current knowledge of miR-26a in renal biology and disease, laying the foundation for exploring its previously unknown functions and mechanisms in the renal system.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Kidney disease; Mesangial cell; Podocyte; Regulatory T cell; miR-26a

Year:  2019        PMID: 31163420     DOI: 10.1159/000499646

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  13 in total

Review 1.  Extracellular vesicle-mediated bidirectional communication between heart and other organs.

Authors:  Khatia Gabisonia; Mohsin Khan; Fabio A Recchia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-18       Impact factor: 4.733

2.  A microRNA checkpoint for Ca2+ signaling and overload in acute pancreatitis.

Authors:  Wenya Du; Geng Liu; Na Shi; Dongmei Tang; Pawel E Ferdek; Monika A Jakubowska; Shiyu Liu; Xinyue Zhu; Jiayu Zhang; Linbo Yao; Xiongbo Sang; Sailan Zou; Tingting Liu; Rajarshi Mukherjee; David N Criddle; Xiaofeng Zheng; Qing Xia; Per-Olof Berggren; Wendong Huang; Robert Sutton; Yan Tian; Wei Huang; Xianghui Fu
Journal:  Mol Ther       Date:  2022-01-22       Impact factor: 12.910

3.  MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.

Authors:  Li Wang; Hua Li
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

Review 4.  The Epigenetic Landscape of Vascular Calcification: An Integrative Perspective.

Authors:  Yi-Chou Hou; Chien-Lin Lu; Tzu-Hang Yuan; Min-Tser Liao; Chia-Ter Chao; Kuo-Cheng Lu
Journal:  Int J Mol Sci       Date:  2020-02-01       Impact factor: 5.923

5.  miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway.

Authors:  Jinchun Shang; Shukai Sun; Lin Zhang; Fengyun Hao; Dianlong Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

6.  Curcumin nicotinate suppresses abdominal aortic aneurysm pyroptosis via lncRNA PVT1/miR-26a/KLF4 axis through regulating the PI3K/AKT signaling pathway.

Authors:  Jian-Ming Xiong; Hui Liu; Jie Chen; Qing-Qing Zou; Yang-Yi-Jing Wang; Guo-Shan Bi
Journal:  Toxicol Res (Camb)       Date:  2021-06-01       Impact factor: 2.680

7.  Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function.

Authors:  Haixia Xu; Xiao Du; Jia Xu; Yu Zhang; Yan Tian; Geng Liu; Xiuxuan Wang; Meilin Ma; Wenya Du; Yu Liu; Lunzhi Dai; Wendong Huang; Nanwei Tong; Yuquan Wei; Xianghui Fu
Journal:  PLoS Biol       Date:  2020-02-24       Impact factor: 8.029

8.  Analysis of microRNA expression profiles in porcine PBMCs after LPS stimulation.

Authors:  Jing Zhang; Xin Xu; Xingfa Huang; Huiling Zhu; Hongbo Chen; Wenjun Wang; Yulan Liu
Journal:  Innate Immun       Date:  2020-01-22       Impact factor: 2.680

Review 9.  MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.

Authors:  Hong Zhou; Wei-Jian Ni; Xiao-Ming Meng; Li-Qin Tang
Journal:  Front Cell Dev Biol       Date:  2021-01-25

Review 10.  Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease.

Authors:  Marcella Liciani Franco; Stephany Beyerstedt; Érika Bevilaqua Rangel
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.